Tempsens Instruments (India) IPO Day 1: GMP ₹170 (+₹20)

The much-anticipated IPO of Tempsens Instruments (India) has officially opened its doors for subscription today, marking the beginning of Day 1. For those keeping a close watch on the Indian stock market, this is a crucial juncture to assess investor sentiment. As of the close of Day 1, the subscription numbers across all categories – Retail, Non-Institutional Investors (NII), and Qualified Institutional Buyers (QIB) – stand at 0x. While this might seem like a slow start, it’s not uncommon for IPOs to see a gradual build-up of interest, especially in the initial days. The issue price is set at ₹300 per share, and the IPO is scheduled to run until August 24th, 2026.

Subscription Status

Let’s break down what these initial ‘0x’ subscription figures actually mean. A zero subscription in the early hours or even the first day doesn’t necessarily spell doom for an IPO. Often, major participation from institutional investors (QIBs) and High Net Worth Individuals (HNIs) within the NII category tends to happen in the latter half of the subscription period. Retail investors, who typically form a significant portion of the applicant base, might also wait to gauge the overall momentum. However, it’s worth noting that a complete absence of bids across all segments on Day 1 can sometimes indicate a cautious market or perhaps a need for further investor education on the company’s prospects. We’ll be keenly watching how these numbers evolve over the next few days. The lot size for this IPO is 50 shares, meaning a single application involves purchasing a block of 50 shares.

GMP Update

Moving on to the Grey Market Premium (GMP), which often acts as a real-time indicator of demand outside the official books. Today, the current GMP for Tempsens Instruments is ₹170. This is a positive development, as it represents an increase of ₹20 from yesterday’s GMP of ₹150. A rising GMP is generally a good sign, suggesting that market participants are willing to pay a premium for the shares even before they list. Based on the issue price of ₹300 and the current GMP of ₹170, the expected listing price is around ₹470. This ₹170 premium is quite substantial and indicates a strong appetite in the unofficial market. The upward trend from yesterday is particularly encouraging and hints at growing confidence in the IPO.

Should You Apply?

So, the million-dollar question: should you be applying for the Tempsens Instruments IPO? It’s a decision that requires a balanced perspective. On one hand, the GMP is showing a healthy and increasing trend, pointing towards a potentially profitable listing. The expected listing price of ₹470, derived from the issue price and GMP, offers a considerable upside. However, the lack of subscription on Day 1 is something to monitor. While not a definitive red flag, it’s a data point that suggests investors are taking a wait-and-watch approach. Remember, the SEBI advisor’s guidance is to always conduct thorough due diligence on the company’s fundamentals, its industry prospects, and its financial health, rather than solely relying on GMP. The IPO period is from August 20th to August 24th, 2026, giving you ample time to make an informed decision. The bottom line is, if the GMP continues its positive trajectory and subscription starts picking up in the coming days, it could be a compelling opportunity.

View Full Tempsens Instruments (India) IPO Details